Troegeler Anthony, Lugo-Villarino Geanncarlo, Hansen Søren, Rasolofo Voahangy, Henriksen Maiken Lumby, Mori Kenichiro, Ohtani Katsuki, Duval Carine, Mercier Ingrid, Bénard Alan, Nigou Jérome, Hudrisier Denis, Wakamiya Nobutaka, Neyrolles Olivier
Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France; Université de Toulouse, Université Paul Sabatier, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France.
Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
PLoS One. 2015 Jul 14;10(7):e0132692. doi: 10.1371/journal.pone.0132692. eCollection 2015.
Understanding the molecular components of immune recognition of the tuberculosis (TB) bacillus, Mycobacterium tuberculosis, can help designing novel strategies to combat TB. Here, we identify collectin CL-LK as a novel soluble C-type lectin able to bind M. tuberculosis, and characterize mycobacterial mannose-capped lipoarabinomannan as a primary ligand for CL-LK. Mice deficient in CL-K1, one of the CL-LK subunits, do not display altered susceptibility to M. tuberculosis. However, we found that the amount of CL-LK in the serum of patients with active TB is reduced, compared to that in controls, and correlates inversely to the magnitude of the immune response to the pathogen. These findings indicate that CL-LK might be of interest for future diagnostic and treatment monitoring purposes.
了解结核分枝杆菌免疫识别的分子成分有助于设计对抗结核病的新策略。在此,我们鉴定出凝集素CL-LK是一种能够结合结核分枝杆菌的新型可溶性C型凝集素,并将分枝杆菌甘露糖封端脂阿拉伯甘露聚糖表征为CL-LK的主要配体。缺乏CL-LK亚基之一CL-K1的小鼠对结核分枝杆菌的易感性没有改变。然而,我们发现,与对照组相比,活动性结核病患者血清中CL-LK的含量降低,且与对病原体的免疫反应强度呈负相关。这些发现表明,CL-LK可能对未来的诊断和治疗监测具有重要意义。